Drug Therapy, Combination
"Drug Therapy, Combination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Therapy with two or more separate preparations given for a combined effect.
| Descriptor ID |
D004359
|
| MeSH Number(s) |
E02.319.310
|
| Concept/Terms |
Drug Therapy, Combination- Drug Therapy, Combination
- Combination Chemotherapy
- Drug Polytherapy
- Drug Polytherapies
- Polytherapies, Drug
- Polytherapy, Drug
- Therapy, Combination Drug
- Chemotherapy, Combination
- Chemotherapies, Combination
- Combination Chemotherapies
- Combination Drug Therapy
- Combination Drug Therapies
- Drug Therapies, Combination
- Therapies, Combination Drug
|
Below are MeSH descriptors whose meaning is more general than "Drug Therapy, Combination".
Below are MeSH descriptors whose meaning is more specific than "Drug Therapy, Combination".
This graph shows the total number of publications written about "Drug Therapy, Combination" by people in this website by year, and whether "Drug Therapy, Combination" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 15 | 15 |
| 1996 | 0 | 18 | 18 |
| 1997 | 1 | 19 | 20 |
| 1998 | 2 | 15 | 17 |
| 1999 | 1 | 10 | 11 |
| 2000 | 1 | 14 | 15 |
| 2001 | 0 | 15 | 15 |
| 2002 | 1 | 18 | 19 |
| 2003 | 4 | 38 | 42 |
| 2004 | 3 | 27 | 30 |
| 2005 | 0 | 23 | 23 |
| 2006 | 0 | 28 | 28 |
| 2007 | 0 | 24 | 24 |
| 2008 | 0 | 32 | 32 |
| 2009 | 0 | 40 | 40 |
| 2010 | 0 | 31 | 31 |
| 2011 | 2 | 42 | 44 |
| 2012 | 1 | 36 | 37 |
| 2013 | 1 | 31 | 32 |
| 2014 | 0 | 37 | 37 |
| 2015 | 1 | 31 | 32 |
| 2016 | 0 | 34 | 34 |
| 2017 | 0 | 35 | 35 |
| 2018 | 4 | 44 | 48 |
| 2019 | 0 | 34 | 34 |
| 2020 | 1 | 31 | 32 |
| 2021 | 0 | 15 | 15 |
| 2022 | 1 | 10 | 11 |
| 2023 | 1 | 16 | 17 |
| 2024 | 3 | 16 | 19 |
| 2025 | 0 | 6 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Therapy, Combination" by people in Profiles.
-
Long-term efficacy and safety of sofosbuvir-based direct-acting antiviral regimens in paediatric patients with hepatitis C virus infection: an international registry study. Lancet Child Adolesc Health. 2025 Apr; 9(4):248-254.
-
Group-based trajectory modeling to identify longitudinal patterns and predictors of adherence among older adults on concomitant triple therapy (oral antidiabetic, renin-angiotensin-system antagonists, statins). J Manag Care Spec Pharm. 2025 Apr; 31(4):396-405.
-
Impact of an Electronic Medical Record Quality Improvement Intervention on Helicobacter pylori Treatment and Eradication Rates in a U.S. Hospital System. Helicobacter. 2025 Mar-Apr; 30(2):e70034.
-
Combined Systemic Immunotherapy and Intrathecal Dexamethasone in Febrile Infection Related Epilepsy Syndrome. Ann Clin Transl Neurol. 2025 Apr; 12(4):871-875.
-
Safety of 3-month rifampicin-isoniazid TPT in child household contacts in a community-based intervention. Int J Tuberc Lung Dis. 2025 Feb 01; 29(2):67-74.
-
Sozinibercept Combination Therapy for Neovascular Age-related Macular Degeneration: Phase 2b Study Subgroup Analysis by Lesion Type. Ophthalmic Surg Lasers Imaging Retina. 2025 May; 56(5):287-296.
-
Budesonide, Added to PTCy-Based Regimen, for Prevention of Acute GI GVHD After Allogeneic Stem Cell Transplantation. Am J Hematol. 2025 Mar; 100(3):383-392.
-
Efficacy of opioid combination versus single opioid for adult cancer pain: a protocol for systematic review and meta-analysis. BMJ Open. 2024 Dec 23; 14(12):e084829.
-
Effects of amoxicillin dosage on cure rate, gut microbiota, and?antibiotic resistome in vonoprazan and amoxicillin dual therapy for Helicobacter pylori: a multicentre, open-label, non-inferiority randomised controlled trial. Lancet Microbe. 2025 Mar; 6(3):100975.
-
Overcoming the effects of increasing antimicrobial resistance on Helicobacter pylori therapy. Expert Rev Gastroenterol Hepatol. 2024 Nov; 18(11):705-711.